KZR vs MCD · $53.9M cap vs P/E 23, rev $25.92B
Kezar Life Sciences Inc (KZR) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
KZR currently screens at market cap $53.9M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the KZR and MCD stock pages for the full models.
Not investment advice.